Comparative Analysis between Monopolar and Bipolar TURP - A Single Institute Prospective Controlled Study

2021 ◽  
Vol 8 (3) ◽  
pp. 1-4
Author(s):  
Prashant Patel ◽  
Krunal Patel
Keyword(s):  
Symptom Score ◽  
Transurethral Resection ◽  
International Prostate Symptom Score ◽  
Controlled Trial ◽  
Surgical Techniques ◽  
Controlled Study ◽  
Transurethral Resection Of Prostate ◽  
Urinary Flow ◽  
Postvoid Residual Urine ◽  
Life Threatening

Background: The ‘gold standard’ surgical treatment of clinically obstructive BPH is TURP, but life-threatening complications such as transurethral resection syndrome are occasionally observed. This has traditionally been provided as monopolar TURP, but morbidity associated with MTURP has led to the introduction of other surgical techniques. Objectives: To compare the effects of bipolar and monopolar TURP. Methods: In this prospective comparative study, 50 patients of each group undergo transurethral resection of prostate were enrolled and randomized to surgery by M‑TURP or B-TURP. International Prostate Symptom Score (IPSS), uroflowmetry, ultrasonography, prevoid, postvoid and international prostate symptom score (IPSS), maximum urinary flow rate (Qmax), postvoid residual urine (PVRU) volume, and prostate volume (PV). Complications and sequelae also assessed. Comparisons performed. Results:No significant differences found in baseline characteristics or operative data, No differences found in IPSS, Qmax or PVRU volume. Conclusions:Based on this controlled trial, there is not significant variation in effectiveness and safety between M-TURP and Bipolar -TURP for the treatment of BPH. Accordingly, M-TURP continues to be a valid option for the treatment of BPE. Keywords: Transurethral resection of prostate, Monopolar, Bipolar.

Evaluation of International Prostate Symptom Score and Quality of Life Following Transurethral Resection of Prostate in Benign Prostatic Hyperplasia

2020 ◽  
Vol 15 (2) ◽  
pp. 27-32
Author(s):  
Md Akter Alam ◽  
Md Abul Hossain ◽  
Md Fazal Naser ◽  
Md Shafiqul Azam ◽  
Md Nurul Hooda ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Symptom Score ◽  
Negative Correlation ◽  
Transurethral Resection ◽  
International Prostate Symptom Score ◽  
Significant Negative Correlation ◽  
Transurethral Resection Of Prostate ◽  
Preoperative Period

Objectives: Evaluation of the international prostate symptom score(IPSS) and quality of life score before and following TURP in BPH patients and correlation with objective parameters(Qmax and PVR). Methods: This purposive clinical trial was carried out in the Department of Urology, Sir Salimullah Medical College and Mitford Hospital, Dhaka, from January 2008 to December 2008. Total fifty patients between 50-72 years attending for the treatment of BPH with LUTS were included for the study according to inclusion & exclusion Patients with carcinoma prostate riteria. Selected patients underwent transurethral resection of prostate. All of them had baseline IPSS, QoL score, Qmax, voided volume, voiding time and PVR. They were followed after 1 month and 3 months with same parameter and compared with the baseline values. Correlation of IPSS and QoL score was done with Qmax and PVR. Results: The baseline IPSS in this study was 25.18±1.45. At one month and three months follow up visits after TURP, the IPSS was decreased to 15.0±1.07 and 8.14±0.76 respectively. The mean QoL score was 5.30± 0.46 before TURP. After one month of TURP it was 3.20± 0.45 and after 3 months of TURP it was 1.86 ± 0.57. There was significant negative correlation between the QoL score and Qmax in the preoperative period (r = -0.606, p=0.001), at the 1st follow up visit after one month of TURP (r = -0.171, p=0.235) and at the 2nd follow visit after three months of TURP (r = -0.680, p =0.001). There was positive correlation between the QoL score and PVR in the preoperative period (r = 0.394, p=0.005), at the 1st follow up visit after one month of TURP (r = 0.047, p =0.748) and at the 2nd follow up visit after three months of TURP (r = 0.471, p=0.235). Conclusion: There was significant improvement of quality of after TURP and There was significant negative correlation between the QoL score and Qmax and positive correlation between the QoL score and PVR. Bangladesh Journal of Urology, Vol. 15, No. 2, July 2012 p.27-32

Impact Of Transurethral Resection Of Prostate On International Prostate Symptom Score And Peak Urinary Flow Rate

2020 ◽  
Vol 16 (1) ◽  
pp. 11-15
Author(s):  
Md Waliul Islam ◽  
Md Abul Hossain ◽  
Md Nurul Hooda ◽  
Kazi Rafiqul Abedin ◽  
Husne Ara
Keyword(s):  
Flow Rate ◽  
Transurethral Resection ◽  
Urine Volume ◽  
T Test ◽  
Urinary Symptoms ◽  
Urinary Flow Rate ◽  
Transurethral Resection Of Prostate ◽  
Urinary Flow ◽  
Paired Student ◽  
The Impact

Objectives: To evaluate urinary symptoms and quality of life in patient with BPH before and after TURP. To determine the impact of TURP on the urinary symptoms (IPSS) and peak urinary flow rate. Methods: This study is prospective study carried out between 2010 and 2011 in the department of Urology, National Institute of Kidney Diseases & Urology. Total 102 cases were selected purposively according to selection criteria. Each patient was observed and followed up at 8 weeks (1st visit), 16 weeks (2nd visit) 24 weeks (3rd visit) after transurethral resection of prostate (TURP). IPSS score, QOL score also recorded and uroflowmetry was done to see the peak urinary flow rate (Qmax) of urine and voiding time. USG was done to see post voidal residual urine volume and DRE also done in selected cases. Data was complied and statistical analysis were done using computer based software, Statistical Package for Social Science (SPSS), using paired ‘t’ test. A P value <0.05 was taken as significance. Results: Before TURP, IPSS range 17-25 and mean 21.61+2.43, after TURP, range 0-7 and mean 4.27+1.71). Hence a significant improvement of IPSS was found from 2 months to 6 months follow up after TURP. The change was tested using “paired student ‘t’ test”. Before TURP Qmax range 7-12.2 and mean was 9.96+1.69, which became range 18-25 and mean was 22.61+2.28 after TURP and therefore change of mean Qmax was 12.64+2.69. The change was tested using “paired student ‘t’ test”. The change was found significant (P<0.001). Conclusion: Transurethral resection of prostate resolves obstructive symptoms, rapid improvement of urinary flow rate Bangladesh Journal of Urology, Vol. 16, No. 1, Jan 2013 p.11-15

scholarly journals The effect of short-term use of finasteride versus cyproterone acetate on perioperative blood loss with monopolar transurethral resection of prostate

2021 ◽  
Vol 27 (1) ◽  
Author(s):  
Shabieb A. Abdelbaki ◽  
Adel Al-Falah ◽  
Mohamed Alhefnawy ◽  
Ahmed Abozeid ◽  
Abdallah Fathi
Keyword(s):  
Blood Loss ◽  
Transurethral Resection ◽  
Cyproterone Acetate ◽  
Histopathological Examination ◽  
Microvascular Density ◽  
Controlled Study ◽  
Control Group ◽  
Transurethral Resection Of Prostate ◽  
Perioperative Bleeding ◽  
And Control

Abstract Background Perioperative bleeding is the most common complication related to transurethral resection of prostate; the aim of the study was to compare the effect of pre-operative use of finasteride versus cyproterone acetate (CPA) on blood loss with monopolar TURP. Methods This prospective randomized controlled study was conducted on (60) patients with BPH underwent monopolar TURP between July 2019 and July 2020. Patients were distributed into three equal groups; CPA group: 20 patients received cyproterone acetate 50 mg tab BID for two weeks before TURP, finasteride group: 20 patients received single daily dose of finasteride 5 mg for two weeks before TURP, control group: 20 patients received no treatment before TURP, all patients underwent monopolar TURP, and then histopathological examination of the resected tissues was done with assessment of the microvascular density of the prostate. Results Our study showed that there was significant decrease in intraoperative blood loss and operative time in CPA and finasteride groups in comparison with control group (p = 0.0012) (p < 0.0001), respectively, significant decrease in post-operative Hb and HCT value in finasteride and control groups in comparison with CPA group (p < 0.01), significant increase in specimen weight in CPA group compared to other groups (p < 0.01), and there was also significant decrease in microvascular density in CPA group in comparison with other groups (p < 0.01). Conclusion Cyproterone acetate is more effective than finasteride in decreasing perioperative bleeding with TURP by decreasing microvascular density of the prostate.

scholarly journals The Effect of Different Metabolic Syndrome

2016 ◽  
Vol 11 (1) ◽  
pp. 158-163 ◽  
Author(s):  
Orhan Ünal Zorba ◽  
Hakkı Uzun ◽  
Görkem Akça ◽  
Selim Yazar
Keyword(s):  
Metabolic Syndrome ◽  
Symptom Score ◽  
Flow Rate ◽  
International Prostate Symptom Score ◽  
Prostate Volume ◽  
Specific Antigen ◽  
Urinary Flow Rate ◽  
Urinary Flow ◽  
Significant Difference ◽  
Maximum Urinary Flow

Because various criteria are used to define metabolic syndrome (MetS), this study examines the most relevant definition for patients with benign prostatic enlargement (BPE). Most studies regarding the link between MetS and BPE/lower urinary tract symptoms (LUTS) have used the National Cholesterol Education Program Adult Treatment Panel III criteria for diagnosis, while a few have used criteria from the International Diabetes Federation and/or American Heart Association. Patients with LUTS due to BPE are classified as having MetS or not by the aforementioned three definitions. Prostate volume, International Prostate Symptom Score, storage and voiding subscores, maximum urinary flow rate, and the postvoid urine of patients with and without MetS were compared separately in the three different groups. Surgical and medical treatment prevalence was also compared between three groups. No matter which definition was used, the International Prostate Symptom Score, the storage and voiding symptom scores, prostate volume, prostate-specific antigen, and postvoid urine were significantly higher in the patients with MetS. The maximum urinary flow rate was similar between patients with and without MetS, according to all three different definitions. There was no significant difference in the aforementioned parameter between patients with MetS diagnosed with the three different definitions. Irrespective of which definition was used, the surgical treatment rate was not significantly different in patients diagnosed with than without MetS, or between the patients with MetS diagnosed with the three different definitions. The authors suggest that it does not matter which of the aforementioned three definitions is used during the evaluation of MetS in men with BPE/LUTS.

scholarly journals A multicentre single-blind randomized controlled trial comparing bipolar and monopolar transurethral resection of the prostate

2013 ◽  
Vol 5 (6) ◽  
pp. 385
Author(s):  
Carlos E. Méndez-Probst ◽  
Linda Nott ◽  
Stephen E. Pautler ◽  
Hassan Razvi
Keyword(s):  
Quality Of Life ◽  
Transurethral Resection ◽  
Controlled Trial ◽  
Transrectal Ultrasound ◽  
Life Assessment ◽  
Urinary Flow ◽  
Tissue Specimens ◽  
Single Blind ◽  
Length Of Hospitalization

Introduction: Monopolar transurethral resection of the prostate(TURP) is the gold standard surgical therapy for men with lower urinarytract symptoms due to benign prostatic hyperplasia. Althoughgenerally considered safer, TURP experience is limited in Canada.Methods: Forty-three patients from 5 Canadian centres were randomizedto TURP with either bipolar or monopolar platforms.Patients underwent baseline determinations of American UrologicalAssociation (AUA) symptom score, peak urinary flow rate, postvoidresidual bladder volume and transrectal ultrasound prostatevolume. Primary outcome measures were improvement in AUAsymptom score, quality of life assessment and bother assessment.Secondary outcomes included procedural times, duration of catheterization,length of hospitalization, complications and the degreeof thermal artifact in tissue specimens. Patients were followed for6 months.Results: Twenty-two patients were treated with bipolar and 21 withmonopolar TURP. Preoperative demographics were not statisticallydifferent between groups. Postoperative data collection times wereequivalent in AUA symptom, quality of life, bother and sexualfunction assessments. No differences were observed in the proceduretime (60.7 min, bipolar vs. 47.4, monopolar) or the durationof urethral catheterization (1.5 days, bipolar vs. 1.1, monopolar).More patients in the bipolar group were discharged on the sameday of surgery. There were no differences in the degree of tissuethermal artifact or complication rate.Conclusion: This trial suggests equivalent short-term outcomes formen undergoing monopolar or bipolar TURP.

scholarly journals Holmium Laser enucleation of the prostate (HoLEP) versus Transurethral Resection of the Prostate (TURP)

2015 ◽  
Vol 42 (3) ◽  
pp. 165-170 ◽  
Author(s):  
Luís Eduardo Durães Barboza ◽  
Osvaldo Malafaia ◽  
Luiz Edison Slongo ◽  
Fernando Meyer ◽  
Paulo Afonso Nunes Nassif ◽  
...  
Keyword(s):  
Surgical Treatment ◽  
Symptom Score ◽  
Flow Rate ◽  
Transurethral Resection ◽  
International Prostate Symptom Score ◽  
Peak Flow ◽  
Prostatic Hyperplasia ◽  
Peak Flow Rate ◽  
Laser Enucleation ◽  
Holmium Laser Enucleation

<sec><title>OBJECTIVE:</title><p>to evaluate the effectiveness and applicability of Holmium laser enucleation of the prostate (HoLEP) - in the treatment of benign prostatic hyperplasia (BPH) - in comparison to transurethral resection of the prostate (TURP).</p></sec><sec><title>METHODS:</title><p>patients with symptomatic prostatic hyperplasia and candidates for surgical treatment were selected. Both procedures were explained and they had choosen HoLEP or TURP. At the hospital were collected: age, date of birth, international prostate symptom score, urinary peak flow rate, prostate volume, post-voiding residual urine, globular volume and serum PSA. At the procedure operating time, morcellating time (HoLEP), bladder mucosal injury and intercurrences were collected. At the first postoperative day, globular volume and sodium. Besides that were observed the catheter indwelling time and hospital stay and after 90 days, urinary peak flow rate and international prostate symptom score. Statistical analisys have been done partially by Sinpe(r) and also by a professional team.</p></sec><sec><title>RESULTS:</title><p>twenty patients in HoLEP group and 21 at TURP were operated. Baseline urinary peak flow rate was 8 ml/s in both groups and preoperative international prostate symptom score was 22 in HoLEP and 20 in TURP, very similar. Operative time was 85 minutes in HoLEP and 60 in TURP, p<0.05. Hospital stay was 47 hours for HoLEP and 48 hours to TURP, p<0.05. At 90 day the urinary peak flow rate was raised to 21.5 ml/s in HoLEP group and to 20 ml/s in TURP and the median of international prostate symptom score had been reduced to score 3 in both groups.</p></sec><sec><title>CONCLUSION:</title><p>HoLEP is a feasible technique and is as effective as TURP on symptomatic prostatic hyperplasia surgical treatment.</p></sec>

Sign in / Sign up

Export Citation Format

Share Document